Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
1.2.1. Antihypertensive Drugs Market, by Region, 2018-2027 (USD Million)
1.2.2. Antihypertensive Drugs Market, by Therapeutic Class, 2018-2027 (USD Million)
1.2.3. Antihypertensive Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Antihypertensive Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Antihypertensive Drugs Market Dynamics
3.1. Antihypertensive Drugs Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Antihypertensive Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Antihypertensive Drugs Market, by Therapeutic Class
5.1. Market Snapshot
5.2. Global Antihypertensive Drugs Market by Therapeutic Class, Performance - Potential Analysis
5.3. Global Antihypertensive Drugs Market Estimates & Forecasts by Therapeutic Class 2017-2027 (USD Million)
5.4. Antihypertensive Drugs Market, Sub Segment Analysis
5.4.1. Diuretics
5.4.2. Angiotensin-Converting Enzyme (ACE) Inhibitors
5.4.3. Calcium Channel Blockers
5.4.4. Vasodilators
5.4.5. Beta-adrenergic Blockers
5.4.6. Others
Chapter 6. Global Antihypertensive Drugs Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Antihypertensive Drugs Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Antihypertensive Drugs Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Million)
6.4. Antihypertensive Drugs Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
Chapter 7. Global Antihypertensive Drugs Market, Regional Analysis
7.1. Antihypertensive Drugs Market, Regional Market Snapshot
7.2. North America Antihypertensive Drugs Market
7.2.1. U.S. Antihypertensive Drugs Market
7.2.1.1. Therapeutic Class breakdown estimates & forecasts, 2017-2027
7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Antihypertensive Drugs Market
7.3. Europe Antihypertensive Drugs Market Snapshot
7.3.1. U.K. Antihypertensive Drugs Market
7.3.2. Germany Antihypertensive Drugs Market
7.3.3. France Antihypertensive Drugs Market
7.3.4. Spain Antihypertensive Drugs Market
7.3.5. Italy Antihypertensive Drugs Market
7.3.6. Rest of Europe Antihypertensive Drugs Market
7.4. Asia-Pacific Antihypertensive Drugs Market Snapshot
7.4.1. China Antihypertensive Drugs Market
7.4.2. India Antihypertensive Drugs Market
7.4.3. Japan Antihypertensive Drugs Market
7.4.4. Australia Antihypertensive Drugs Market
7.4.5. South Korea Antihypertensive Drugs Market
7.4.6. Rest of Asia Pacific Antihypertensive Drugs Market
7.5. Latin America Antihypertensive Drugs Market Snapshot
7.5.1. Brazil Antihypertensive Drugs Market
7.5.2. Mexico Antihypertensive Drugs Market
7.6. Rest of The World Antihypertensive Drugs Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Boehringer Ingelheim International GmbH
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Merck & Co., KGaA
8.2.3. Johnson and Johnson
8.2.4. Bayer AG
8.2.5. Pfizer, Inc.
8.2.6. Takeda Pharmaceutical Co. Ltd.
8.2.7. AstraZeneca plc
8.2.8. Daiichi Sankyo Company, Ltd.
8.2.9. Sanofi S.A.
8.2.10. Novartis International AG
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption